
Chaitanya Iragavarapu
Associate Professor · University of Kentucky College of Medicine
Credentials: · · · · · · ·
History

- Present
- 2007–2011
Research
ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development
Review · Journal of Hematology & Oncology · 2015 · 233 citations
Novel ALK inhibitors in clinical use and development
Review · Journal of Hematology & Oncology · 2015 · First of 7 authors · 84 citations
Novel agents for advanced pancreatic cancer
Review · Oncotarget · 2015 · 27 citations
- DL
5 papers

2 papers

2 papers

2 papers
- KL
2 papers · 2 as a resident

2 papers
- RM
2 papers

2 papers
Clinical trials
- 2024–2032
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Site PI · Recruiting · Phase 2
Allogene Therapeutics
- 2021–2027
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology


